Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines

Experimental Lung Research

Volumn 27, Issue 3, 2001, Pages 297-318

  McDoniels Silvers, A L ^a   Herzog, C R ^a   Tyson, F L ^a   Malkinson, A M ^a   You, M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cell cycle regulation; Cell lines; Lung tumor; Mouse

Indexed keywords

CYCLIN D1; PHOSPHOPROTEIN; PROTEIN P16; PROTEIN P19; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; CELL CYCLE PHASE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CHROMOSOME DELETION; CONFERENCE PAPER; DNA METHYLATION; GENE EXPRESSION; GENETIC REGULATION; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE;

EID: 0035083738     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021401300054064     Document Type: Conference Paper

References (85)

1. Database of p53 gene somatic mutations in human tumors and cell lines
2. Tumor surveillance via the ARF-p53 pathway
3. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
4. Cancer cell cycles
5. Mutations and altered expression of p16INK4 in human cancer
6. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression
7. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas
8. ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
9. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
10. The complexity of p53 modulation: Emerging patterns from divergent signals
11. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
12. Participation of p53 protein in the cellular response to DNA damage
13. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
14. Mediation of c-Myc-induced apoptosis by p53
15. INK4a
16. E1A signaling to p53 involves the p19(ARF) tumor suppressor
17. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
18. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53
19. MDM2 gene amplification in metastatic osteosarcoma
20. p53 mutation and MDM2 amplification in human soft tissue sarcomas
21. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma
22. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2
23. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
24. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene
25. Mdm2 promotes the rapid degradation of p53
26. Regulation of p53 stability by Mdm2
27. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
28. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
29. Interaction between the retinoblastoma protein and the oncoprotein MDM2
30. p53-independent role of MDM2 in TGF-betal resistance
31. RB regulates the stability and the apoptotic function of p53 via MDM2
32. ARF act in overlapping pathways in cellular immortalization
33. INK4a
34. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
35. The retinoblastoma protein and cell cycle control
36. INK4a/CDKN2A minor suppressor and its relatives
37. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines
38. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
39. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas
40. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines
41. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - Relationship to amplification and mRNA levels of CDK4 and CCND1
42. ARF
43. INK4a expression in resected non-small cell lung tumors
44. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: Potential synergistic effect with altered p53 protein on proliferative activity
45. INK4a gene is frequently lost in small cell lung cancer
46. Characterization of a neoplastic epithelial cell strain derived by dexamethasone treatment of cultured normal mouse type 2 pneumocytes
47. Altered function of protein kinase C and cyclic adenosine monophosphate-dependent protein kinase in a cell line derived from a mouse lung papillary tumor
48. Malignant Clara cell line derived from ethylnitrosourea-induced routine lung adenomas
49. Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor
50. INK4a-beta in mouse lung tumor cells
51. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
52. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin
53. Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors
54. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
55. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology, and molecular pathogenesis
56. p53 website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis
57. INK4a/MTS1 gene
58. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
59. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
60. Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cip1/Sdi1) gene expression in hepatic regeneration
61. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation
62. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
63. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma
64. Progress in understanding the molecular pathogenesis of human lung cancer
65. Signaling to p53: Breaking the MDM2-p53 circuit
66. p53, the cellular gatekeeper for growth and division
67. Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects
68. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice
69. Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors
70. The retinoblastoma protein pathway and the restriction point
71. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb
72. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence
73. Cell-cycle regulators and cancer
74. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
75. Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene
76. INK4a in mouse lung tumors
77. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma
78. INK4a: A gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression
79. ARF encoding exons in T-cell acute lymphoblastic leukemia
80. p14ARF links the tumour suppressors RB and p53
81. pRB plays an essential role in cell cycle arrest induced by DNA damage
82. p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells
83. The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 function
84. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
85. Cooperative tumorigenic effects of germline mutations in Rb and p53